Literature DB >> 21742039

Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system.

Iftiin Hassan Mohamed1, Carmine Giorgio, Renato Bruni, Lisa Flammini, Elisabetta Barocelli, Damiano Rossi, Giuseppe Domenichini, Ferruccio Poli, Massimiliano Tognolini.   

Abstract

The Eph tyrosine kinase receptors and their ephrin ligands play a central role in several human cancers and their deregulated expression or function promotes tumorigenesis, inducing aggressive tumor phenotypes. Green tea extracts (GTE) have been recently found to inhibit Eph-kinase phosphorylation. In order to evaluate the potential contribution of edible and medicinal plants on EphA2-ephrinA1 modulation, 133 commercially available plant extracts used as food supplements, essential and fixed oils were screened with an ELISA-based binding assay. Nine plant extracts, rich of polyphenols, reversibly inhibited binding in a dose-dependent manner (IC₅₀ 0.83-24 μg/ml). Functional studies on PC3 prostate adenocarcinoma cells revealed that active extracts antagonized ephrinA1-Fc-induced EphA2-phosphorylation at non-cytotoxic concentrations (IC₅₀ 0.31-11.3 μg/ml) without interfering with EGF-induced EGFR activation, suggesting a specific effect. These findings could furnish an interesting starting point regarding the potential relationship between diet, edible plant secondary metabolites and Eph-ephrin system, suggesting their possible involvement in cancer development modulation.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742039     DOI: 10.1016/j.phrs.2011.06.008

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  8 in total

Review 1.  Targeting Eph receptors with peptides and small molecules: progress and challenges.

Authors:  Roberta Noberini; Ilaria Lamberto; Elena B Pasquale
Journal:  Semin Cell Dev Biol       Date:  2011-10-25       Impact factor: 7.727

2.  Structure-activity relationships and mechanism of action of Eph-ephrin antagonists: interaction of cholanic acid with the EphA2 receptor.

Authors:  Massimiliano Tognolini; Matteo Incerti; Iftiin Hassan-Mohamed; Carmine Giorgio; Simonetta Russo; Renato Bruni; Barbara Lelli; Luisa Bracci; Roberta Noberini; Elena B Pasquale; Elisabetta Barocelli; Paola Vicini; Marco Mor; Alessio Lodola
Journal:  ChemMedChem       Date:  2012-04-23       Impact factor: 3.466

3.  Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols.

Authors:  Roberta Noberini; Mitchell Koolpe; Ilaria Lamberto; Elena B Pasquale
Journal:  Pharmacol Res       Date:  2012-06-28       Impact factor: 7.658

4.  Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor.

Authors:  Matteo Incerti; Massimiliano Tognolini; Simonetta Russo; Daniele Pala; Carmine Giorgio; Iftiin Hassan-Mohamed; Roberta Noberini; Elena B Pasquale; Paola Vicini; Silvia Piersanti; Silvia Rivara; Elisabetta Barocelli; Marco Mor; Alessio Lodola
Journal:  J Med Chem       Date:  2013-03-22       Impact factor: 7.446

5.  UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations.

Authors:  I Hassan-Mohamed; C Giorgio; M Incerti; S Russo; D Pala; E B Pasquale; I Zanotti; P Vicini; E Barocelli; S Rivara; M Mor; A Lodola; M Tognolini
Journal:  Br J Pharmacol       Date:  2014-08-28       Impact factor: 8.739

Review 6.  Therapeutic potential of targeting the Eph/ephrin signaling complex.

Authors:  Nayanendu Saha; Dorothea Robev; Emilia O Mason; Juha P Himanen; Dimitar B Nikolov
Journal:  Int J Biochem Cell Biol       Date:  2018-10-19       Impact factor: 5.085

7.  Hypoxia-Induced Cleavage Of Soluble ephrinA1 From Cancer Cells Is Mediated By MMP-2 And Associates With Angiogenesis In Oral Squamous Cell Carcinoma.

Authors:  Ting-Ting Ma; Lin Wang; Jun-Lin Wang; Yan-Jie Liu; Yu-Cong Chen; Hu-Jie He; Yong Song
Journal:  Onco Targets Ther       Date:  2019-10-14       Impact factor: 4.147

Review 8.  Targeting EphA2 in cancer.

Authors:  Ta Xiao; Yuhang Xiao; Wenxiang Wang; Yan Yan Tang; Zhiqiang Xiao; Min Su
Journal:  J Hematol Oncol       Date:  2020-08-18       Impact factor: 17.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.